|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00642505
|
|
|
SPDA1
|
[NCBI]
|
0.00219592
|
|
|
IS1
|
[NCBI]
|
0.000598811
|
|
|
TNF
|
[NCBI]
|
0.000331634
|
|
|
TNFRSF11B
|
[NCBI]
|
9.59844e-05
|
|
|
TLR4
|
[NCBI]
|
8.89614e-05
|
|
|
LY6G6D
|
[NCBI]
|
7.61315e-05
|
|
|
g6b protein
|
[NCBI]
|
7.61315e-05
|
|
|
TAP2
|
[NCBI]
|
5.71586e-05
|
|
|
FCRL3
|
[NCBI]
|
5.71586e-05
|
|
|
ankylosing vertebral hyperostosis with tylosis
|
[NCBI]
|
5.41396e-05
|
|
|
TNFSF13
|
[NCBI]
|
5.37854e-05
|
|
|
MARCO
|
[NCBI]
|
5.12783e-05
|
|
|
MG
|
[NCBI]
|
5.10538e-05
|
|
|
TAP1
|
[NCBI]
|
4.92814e-05
|
|
|
IL23R
|
[NCBI]
|
4.76215e-05
|
|
|
PTH
|
[NCBI]
|
4.39739e-05
|
|
|
PDCD1
|
[NCBI]
|
4.19665e-05
|
|
|
CYP2D6
|
[NCBI]
|
3.90165e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
3.67103e-05
|
|
|
TNFSF13B
|
[NCBI]
|
3.62598e-05
|
|
|
HLA-B
|
[NCBI]
|
3.62598e-05
|
|
|
HP
|
[NCBI]
|
3.34995e-05
|
|
|
MICA
|
[NCBI]
|
3.33718e-05
|
|
|
ENPP1
|
[NCBI]
|
3.30213e-05
|
|
|
PPIA
|
[NCBI]
|
3.26831e-05
|
|
|
MMP3
|
[NCBI]
|
3.23564e-05
|
|
|
THC2
|
[NCBI]
|
2.88549e-05
|
|
|
IL4
|
[NCBI]
|
2.60121e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
2.50867e-05
|
|
|
CCAL2
|
[NCBI]
|
2.11244e-05
|
|
|
CML
|
[NCBI]
|
1.70055e-05
|
|
|
GPI
|
[NCBI]
|
1.56366e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.53611e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
1.36976e-05
|
|
|
PI
|
[NCBI]
|
1.19413e-05
|
|
|
SLE
|
[NCBI]
|
1.02046e-05
|
|
|
SOD2
|
[NCBI]
|
8.98723e-06
|
|
|
TFPI
|
[NCBI]
|
8.48505e-06
|
|
|
VEGF
|
[NCBI]
|
4.63971e-06
|
|
|
ACH
|
[NCBI]
|
3.89583e-06
|
|
|
MPO
|
[NCBI]
|
3.21291e-06
|
|
|
RNASE3
|
[NCBI]
|
3.06928e-06
|
|
|
CEACAM5
|
[NCBI]
|
2.77018e-06
|
|
|
PRL
|
[NCBI]
|
1.71237e-06
|
|
|
FMF
|
[NCBI]
|
1.21492e-06
|
|
|
HGF
|
[NCBI]
|
4.65069e-07
|
|
|
AR
|
[NCBI]
|
1.20178e-07
|
|
|
NGFB
|
[NCBI]
|
4.07634e-08
|
|